If you would like to ask our webinar guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksThe Mission Group Regulatory News (TMG)

Share Price Information for The Mission Group (TMG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 24.00
Bid: 23.00
Ask: 25.00
Change: 0.00 (0.00%)
Spread: 2.00 (8.696%)
Open: 24.00
High: 24.00
Low: 24.00
Prev. Close: 24.00
TMG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

12 Jan 2023 07:00

RNS Number : 4485M
Mission Group PLC (The)
12 January 2023
 

12 January 2023

 

The MISSION Group plc

("MISSION" "The Company" or "The Group")

TRADING UPDATE AND NOTICE OF RESULTS

MISSION Group plc (AIM: TMG), creator of Work That CountsTM, comprising a group of digital marketing and communications Agencies delivering real, sustainable growth for its Clients, is pleased to issue a trading update for the financial year ended 31 December 2022.

Trading Update

The Group continued to see a resilient underlying performance from its Agencies in the second half of the financial year, despite the weakening macro-economic backdrop. Increasing exposure to more robust sectors and geographies, coupled with the benefits of the investments MISSION has made to expand its capabilities and services, have underpinned year-on-year Group revenue growth of 10%, slightly ahead of expectation.

Careful control of costs has remained a priority throughout the year, and the Group has balanced this with a commitment to build a strong platform to support growth through continued investment in our talent base. Despite inflationary headwinds and higher finance costs, the Group expects to report Headline Profit before Tax of not less than £7.6m, ahead of the prior year.

Further progress has been made against the Group's strategic areas of focus, expanding its capabilities whilst also improving structural efficiencies to create operational improvements. 

As part of the Group's strategy to strengthen the integrated communications offering of its Agencies, further acquisitions were made in H2 of Influence Sports & Media and social media agency Populate, by the Group's Sports Marketing Agency Mongoose. These follow the successful acquisition of the youth focussed creative business Livity in H1.

MISSION has fundamentally restructured its Asian operations, where performance has been impacted by the extended effect of COVID-19 on the region, and has reviewed the progress and potential of Pathfindr, the Group's Industrial IoT solutions business. Taken together, these actions will result in exceptional restructuring costs, and a non-cash Goodwill impairment charge, in the region of £6m at the year end.

The effect of these restructuring costs and acquisitions, was that Net Debt closed at £11.4m. The Group continues to benefit from significant headroom against its current debt facility of £20m to support its strategic goals and remains cash generative, with Net Debt expected to reduce significantly in 2023. 

Board Update

Executive Director Sue Mullen will be retiring from the Board with immediate effect but will remain with the Group as Chair of Story.

Notice of Results The Group expects to announce its final results on 28 March 2023.

Commenting, James Clifton, Chief Executive Officer of MISSION said:

"In a year of social and political turmoil with unprecedented cost and inflationary challenges MISSION has delivered a robust performance in 2022, building on the strong momentum established in the prior year. 2023 has started well with new Client wins meaning that despite the continued economic uncertainties creating challenges for all businesses, we will continue to exploit the opportunities available to us. The Group has a clear strategic focus that means we are well positioned for revenue and margin growth both in 2023 and the longer term."

 

ENDS

ENQUIRIES:

James Clifton, Chief Executive Officer

Giles Lee, Chief Financial Officer

The MISSION Group plc

 

 

020 7462 1415

 

Mark Percy / James Thomas 

Fiona Conroy (Corporate Broking)

Shore Capital (Nomad and Broker)

 

020 7408 4090

 

 

Kate Hoare / Alexander Clelland / India Spencer

HOUSTON (Financial PR and Investor Relations)

0204 529 0549

 

NOTES TO EDITORS

MISSION is a group of digital marketing and communications Agencies. Employing 1,000 people across 27 locations and three continents, the Group successfully combines its diverse expertise to produce Work That CountsTM for our Clients, whatever their ambitions. Creating real standout, sharing real innovation and delivering real business growth for some of the world's biggest brands. www.themission.co.uk

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTUAABROWUAAAR
Date   Source Headline
11th Mar 20214:40 pmRNSDirector/PDMR Shareholding
24th Feb 20217:00 amRNSHolding(s) in Company
22nd Feb 20215:37 pmRNSDirector/PDMR Shareholding
9th Feb 20219:24 amRNSDirector/PDMR Shareholding
25th Jan 20214:40 pmRNSSecond Price Monitoring Extn
25th Jan 20214:35 pmRNSPrice Monitoring Extension
20th Jan 20217:00 amRNSTrading Update and Notice of Results
11th Nov 20204:58 pmRNSHolding(s) in Company
23rd Sep 20207:00 amRNSInterim Results
27th Jul 20207:00 amRNSACQUISITION OF INNOVATIONBUBBLE
15th Jul 20207:00 amRNSTrading Statement and Notice of Interim Results
15th Jun 20203:37 pmRNSResult of AGM
21st May 20207:00 amRNSCovid-19 and AGM Update
11th May 20204:58 pmRNSDirector Dealing and Issue of Consideration Shares
17th Apr 20203:36 pmRNSIssue of Equity
7th Apr 20205:00 pmRNSPDMR Shareholding pursuant to Growth Share Scheme
1st Apr 20207:00 amRNSFinal Results for the year ended 31 December 2019
27th Mar 20205:22 pmRNSCOVID-19 UPDATE
25th Mar 202011:05 amRNSSecond Price Monitoring Extn
25th Mar 202011:00 amRNSPrice Monitoring Extension
13th Mar 20202:22 pmRNSHolding(s) in Company
22nd Jan 20207:00 amRNSTrading Update
9th Dec 201911:55 amRNSDirector/PDMR Shareholding
5th Dec 20197:00 amRNSLaunch of Global Competition
25th Sep 20197:00 amRNSChange of Name
25th Sep 20197:00 amRNSHalf-year Report
13th Aug 20197:00 amRNSEBT Share Dealings
7th Aug 20198:15 amRNSEBT Share Dealings
1st Aug 20191:11 pmRNSDirector/PDMR Shareholding - Replacement
1st Aug 20197:00 amRNSDirector/PDMR Shareholding
15th Jul 20197:00 amRNSTrading Update
17th Jun 201912:57 pmRNSResult of AGM
17th Jun 201911:58 amRNSBoard Changes
12th Jun 20195:26 pmRNSDirector/PDMR Shareholding
7th Jun 20199:34 amRNSEBT Share Dealings
6th Jun 20191:17 pmRNSEBT Share Dealings
5th Jun 201912:03 pmRNSEBT Share Dealings
4th Jun 20197:00 amRNSGrowth Share Scheme
20th May 20195:18 pmRNSDirector/PDMR Shareholding
23rd Apr 20192:36 pmRNSDirector/PDMR Shareholding
23rd Apr 20199:53 amRNSDirector/PDMR Shareholding
9th Apr 20197:01 amRNSIssue of Equity
9th Apr 20197:00 amRNSFinal Results & Board Changes
22nd Jan 20197:00 amRNSTrading update and Notice of results
5th Dec 20181:43 pmRNSDirector/PDMR Shareholding
23rd Nov 20185:25 pmRNSDirector/PDMR Shareholding
15th Nov 20187:00 amRNSDirector/PDMR Shareholding
12th Nov 20187:00 amRNSDisposal
19th Sep 20187:00 amRNSHalf-year Report
26th Jul 20187:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.